Found 4 results
Filters: Author is C.A. Palafox-Sánchez  [Clear All Filters]
M. Vázquez-Villamar, Palafox-Sánchez, C. A., Hernández-Bello, J., Muñoz-Valle, J. F., Valle, Y., Cruz, A., Alatorre-Meza, A. I., and Oregon-Romero, E., Frequency distribution of interleukin-10 haplotypes (-1082 A>G, -819 C>T, and -592 C>A) in a Mexican population, vol. 15, no. 4, p. -, 2016.
Conflicts of interestThe authors declare no conflict of interest.ACKNOWLEDGMENTSResearch supported by grants provided by CONACYT (Fondo Sectorial SSA/IMSS/ISSSTE-CONACYT, México-Universidad de Guadalajara; Grant #88046 to E. Oregon-Romero and Grant #115567 to C.A. Palafox-Sánchez). REFERENCESAguirre-Beltrán G (1989). La población negra de México, estudio etnohistórico. In: Fondo de Cultura Económica, México D.F. Asadullah K, Sterry W, Volk HD, et al (2003). Interleukin-10 therapy--review of a new approach. Pharmacol. Rev. 55: 241-269. Boiardi L, Casali B, Farnetti E, Pipitone N, et al (2006). Interleukin-10 promoter polymorphisms in giant cell arteritis. Arthritis Rheum. 54: 4011-4017. Chen XH, Xiong JH, Ning Y, Wen Y, et al (2013). IL-10 promoter SNPs and susceptibility to leprosy in ethnic groups from southwest China. Genet. Mol. Res. 12: 2876-2885. Çil E, Kumral A, Kanmaz-Özer M, Vural P, et al (2014). Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer. Mol. Biol. Rep. 41: 3091-3097. Eskdale J, Gallagher G, et al (1995). A polymorphic dinucleotide repeat in the human IL-10 promoter. Immunogenetics 42: 444-445. Excoffier L, Slatkin M, et al (1995). Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol. Biol. Evol. 12: 921-927. Fei C, Yao XM, Sun Y, Gu XZ, et al (2015). Interleukin-10 polymorphisms associated with susceptibility to acute myeloid leukemia. Genet. Mol. Res. 14: 925-930. Font J, García-Carrasco M, Ramos-Casals M, Aldea AI, et al (2002). The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjögren’s syndrome. Rheumatology (Oxford) 41: 1025-1030. Fragoso JM, Vallejo M, Alvarez-León E, Delgadillo H, et al (2011). Alleles and haplotypes of the interleukin 10 gene polymorphisms are associated with risk of developing acute coronary syndrome in Mexican patients. Cytokine 55: 29-33. G e I Instituto Nacional de Estadística (2010). Censo General de Población y Vivienda. INEGI, México D.F. Gérard N, Berriche S, Aouizérate A, Diéterlen F, et al (2006). North African Berber and Arab influences in the western Mediterranean revealed by Y-chromosome DNA haplotypes. Hum. Biol. 78: 307-316. Grunberg B (2004). El universo de los conquistadores: resultado de una investigación prosopográfica. In: Signos Históricos, Universidad Autónoma Metropolitana-Iztapalapa, México D.F. 12: 94-118. Hedrich CM, Bream JH, et al (2010). Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol. Res. 47: 185-206. Hofmann SR, Rösen-Wolff A, Tsokos GC, Hedrich CM, et al (2012). Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury. Clin. Immunol. 143: 116-127. Hua MC, Chao HC, Yao TC, Lai MW, PATCH Study Groupet al (2013). Investigation of interleukin-10 promoter polymorphisms and interleukin-10 levels in children with irritable bowel syndrome. Gut Liver 7: 430-436. Lander E, Kruglyak L, et al (1995). Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11: 241-247. Lewontin RC, et al (1964). The interaction of selection and linkage. I. general considerations; heterotic models. Genetics 49: 49-67. Lisker R, Ramírez E, Babinsky V, et al (1996). Genetic structure of autochthonous populations of Meso-America: Mexico. Hum. Biol. 68: 395-404. Liu J, Song B, Bai X, Liu W, et al (2010). Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese. BMC Cancer 10: 456. Meenagh A, Williams F, Ross OA, Patterson C, et al (2002). Frequency of cytokine polymorphisms in populations from western Europe, Africa, Asia, the Middle East and South America. Hum. Immunol. 63: 1055-1061. Mege JL, Meghari S, Honstettre A, Capo C, et al (2006). The two faces of interleukin 10 in human infectious diseases. Lancet Infect. Dis. 6: 557-569. Miller SA, Dykes DD, Polesky HF, et al (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215. Mocellin S, Panelli MC, Wang E, Nagorsen D, et al (2003). The dual role of IL-10. Trends Immunol. 24: 36-43. Mok CC, Lanchbury JS, Chan DW, Lau CS, et al (1998). Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum. 41: 1090-1095.<1090::AID-ART16>3.0.CO;2-6 Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A, et al (2001). Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19: 683-765. Ouyang W, Rutz S, Crellin NK, Valdez PA, et al (2011). Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 29: 71-109. Pestka S, Krause CD, Sarkar D, Walter MR, et al (2004). Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 22: 929-979. Qi M, Liu DM, Pan LL, Lin YX, et al (2014). Interleukin-10 gene -592C>A polymorphism and susceptibility to gastric cancer. Genet. Mol. Res. 13: 8954-8961. Qin B, Wang J, Liang Y, Yang Z, et al (2013). The association between TNF-α, IL-10 gene polymorphisms and primary Sjögren’s syndrome: a meta-analysis and systemic review. PLoS One 8: e63401. Rangel-Villalobos H, Muñoz-Valle JF, González-Martín A, Gorostiza A, et al (2008). Genetic admixture, relatedness, and structure patterns among Mexican populations revealed by the Y-chromosome. Am. J. Phys. Anthropol. 135: 448-461. Rubi-Castellanos R, Martínez-Cortés G, Muñoz-Valle JF, González-Martín A, et al (2009). Pre-Hispanic Mesoamerican demography approximates the present-day ancestry of Mestizos throughout the territory of Mexico. Am. J. Phys. Anthropol. 139: 284-294. Santos AR, Suffys PN, Vanderborght PR, Moraes MO, et al (2002). Role of tumor necrosis factor-alpha and interleukin-10 promoter gene polymorphisms in leprosy. J. Infect. Dis. 186: 1687-1691. Saraiva M, O’Garra A, et al (2010). The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10: 170-181. Scarpelli D, Cardellini M, Andreozzi F, Laratta E, et al (2006). Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian italian subjects. Diabetes 55: 1529-1533. Schurr TG, Sherry ST, et al (2004). Mitochondrial DNA and Y chromosome diversity and the peopling of the Americas: evolutionary and demographic evidence. Am. J. Hum. Biol. 16: 420-439. Shpak M and Gavrilets S (2001). Population genetics: Multilocus. eLS, John Wiley and Sons, Chichester. Suárez A, Castro P, Alonso R, Mozo L, et al (2003). Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation 75: 711-717. Vargas-Alarcon G, Ramírez-Bello J, Juárez-Cedillo T, Ramírez-Fuentes S, et al (2012). Distribution of the IL-1RN, IL-6, IL-10, INF-γ, and TNF-α Gene Polymorphisms in the Mexican Population. Genet. Test. Mol. Biomarkers 16: 1246-1253. Ying B, Shi Y, Pan X, Song X, et al (2011). Association of polymorphisms in the human IL-10 and IL-18 genes with rheumatoid arthritis. Mol. Biol. Rep. 38: 379-385. Yu YF, Han ZG, Guo WB, Zhang GJ, et al (2015). Interleukin-10 polymorphisms and nasopharyngeal carcinoma risk: a meta-analysis. Genet. Mol. Res. 14: 18945-18957.  
A. L. Fletes-Rayas, Palafox-Sánchez, C. A., Muñoz-Valle, J. F., Orozco-Barocio, G., Navarro-Hernández, R. E., Oregon-Romero, E., Fletes-Rayas, A. L., Palafox-Sánchez, C. A., Muñoz-Valle, J. F., Orozco-Barocio, G., Navarro-Hernández, R. E., and Oregon-Romero, E., TNFR1-383 A˃C polymorphism association with clinical manifestations in primary Sjögren’s syndrome patients, vol. 15, p. -, 2016.
A. L. Fletes-Rayas, Palafox-Sánchez, C. A., Muñoz-Valle, J. F., Orozco-Barocio, G., Navarro-Hernández, R. E., Oregon-Romero, E., Fletes-Rayas, A. L., Palafox-Sánchez, C. A., Muñoz-Valle, J. F., Orozco-Barocio, G., Navarro-Hernández, R. E., and Oregon-Romero, E., TNFR1-383 A˃C polymorphism association with clinical manifestations in primary Sjögren’s syndrome patients, vol. 15, p. -, 2016.